Thomson Reuters/Uni...
Health Care: Drugs
Cerus Corporation (CERS: NASDAQ)
$5.48 0.13 | 2.43%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 26.70M | 25.50M | 28.95M | 17.29M |
| Receivables | 4.44M | 6.10M | 4.79M | 3.62M |
| Inventories | 10.18M | 6.44M | 5.96M | 7.71M |
| Other Current Assets | 2.68M | 1.42M | 0.00 | 0.00 |
| Total Current Assets | 44.00M | 39.74M | 41.76M | 32.36M |
| Property, Plant & Equipment, Gross | 10.02M | 10.07M | 9.89M | 11.58M |
| Accumulated Depreciation & Depletion | 8.32M | 8.04M | 7.50M | 10.37M |
| Property, Plant & Equipment, Net | 1.70M | 2.03M | 2.39M | 1.22M |
| Intangibles | 1.55M | 1.75M | 1.95M | 0.00 |
| Other Non-Current Assets | 363.00K | 532.00K | 756.00K | 915.00K |
| Total Non-Current Assets | 4.92M | 5.63M | 6.41M | 2.13M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 48.92M | 45.37M | 48.17M | 34.49M |
| Accounts Payable | 7.19M | 4.68M | 3.23M | 4.42M |
| Short Term Debt | 4.83M | 2.52M | 1.76M | 9.00K |
| Other Current Liabilities | 5.90M | 7.98M | 8.46M | 2.74M |
| Total Current Liabilities | 25.61M | 21.11M | 19.70M | 12.91M |
| Long Term Debt | 2.90M | 4.70M | 3.13M | 0.00 |
| Deferred Income Taxes | 62.00K | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 1.24M | 1.24M | 1.60M | 115.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 4.20M | 5.94M | 4.73M | 130.00K |
| Total Liabilities | 29.81M | 27.05M | 24.44M | 13.04M |
| Preferred Stock Equity | 0.00 | 9.50M | 9.50M | 9.50M |
| Common Stock Equity | 19.11M | 8.82M | 14.24M | 11.95M |
| Common Par | 56.00K | 51.00K | 47.00K | 39.00K |
| Additional Paid In Capital | 478.90M | 452.70M | 441.03M | 421.90M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -459.85M | -443.94M | -426.95M | -410.04M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 108.00K | 58.00K |
| Total Capitalization | 22.00M | 23.01M | 26.86M | 21.45M |
| Total Equity | 19.11M | 18.31M | 23.73M | 21.45M |
| Total Liabilities & Stock Equity | 48.92M | 45.37M | 48.17M | 34.49M |
| Total Common Shares Outstanding | 56.25M | 51.21M | 47.33M | 38.68M |
| Preferred Shares | 0.00 | 3.00K | 3.00K | 3.00K |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 54.52M | 48.05M | 40.30M | 34.75M |
| Diluted Weighted Shares Outstanding | 55.06M | 48.05M | 40.30M | 34.75M |
| Number of Employees | 85 | 82 | 79 | 73 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CERS
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- UserRASHID 1
- Contributor5 Bargain Biotech Stocks
- UserImagine!
- UserSUPRATRADE - 8 Hot Stocks t...
- UserShake & Bakkke
- Sharespy
- Usermoneymag7 Portfolio 1
- Useriornhorse
Latest CERS Headlines from TheStreet
- 5 Stocks Poised for Breakouts 09.28.12 | 01:09 pm
- 5 Stocks Poised for Breakouts 07.13.12 | 12:07 pm
- Insiders Trading CERS, IL, MDCA, UA 05.09.11 | 08:05 am
- Cerus Stock Gaps Down On Today's Open (CERS) 03.04.11 | 09:03 am
- 5 Bargain Biotech Stocks 01.13.11 | 05:01 pm
- Jones Soda, Callon Petroleum: Early Volume Plays 03.09.10 | 09:03 am
- China BAK, Euro Tech: Early Volume Plays 02.09.10 | 10:02 am
- Biotech Stock Mailbag: FDA Playbook 11.20.09 | 06:11 am
- Playboy, Helicos: Early Volume Plays 11.17.09 | 09:11 am
- Friday's Health Winners & Losers 05.02.08 | 03:05 pm
Press Releases for CERS
- Cerus Signs INTERCEPT Platelet Agreements With Two Key Blood Component Suppliers In Germany And Austria - Business Wire 03.15.13 | 08:03 am
- Cerus Prices Public Offering Of Common Stock - Business Wire 03.14.13 | 09:03 am
- Cerus Corporation Reports Fourth Quarter And Year-End 2012 Results - Business Wire 02.28.13 | 04:02 pm
- Cerus To Present At The Cowen And Company 33rd Annual Health Care Conference On March 6, 2013 - Business Wire 02.27.13 | 08:02 am
- Cerus To Release Fourth Quarter And Year-End 2012 Results On February 28, 2013 - Business Wire 02.14.13 | 08:02 am
- Cerus Announces FDA Agreement On Modular Premarket Approval Application (PMA) Submission Process For INTERCEPT Plasma - Business Wire 12.13.12 | 08:12 am
- Cerus Signs Agreement With Swiss Red Cross For Initial Deployment Of The INTERCEPT Blood System For Plasma - Business Wire 12.04.12 | 08:12 am
- Cerus To Present At The Piper Jaffray Healthcare Conference On November 28, 2012 - Business Wire 11.21.12 | 08:11 am
- Cerus To Present At The Stephens Fall Investment Conference On November 14, 2012 - Business Wire 11.08.12 | 09:11 am
- Cerus To Present At The Lazard Capital Markets 9th Annual Healthcare Conference On November 14, 2012 - Business Wire 11.08.12 | 08:11 am
Partner Headlines for CERS
- After Hours Most Active for Mar 1, 2013 : CERS, SIRI, ABT, SBGL, ABBV, VOD, BAC, NOK, QQQ, AMD, INTC, HOLX - NASDAQ 03.01.13 | 09:03 pm
- Low-Priced Biotech Stocks With Insider Buying - Seeking Alpha 03.18.11 | 06:03 pm
- Company News for March 07, 2011 - Corporate Summary - Zacks 03.07.11 | 10:03 am
- UPDATE 1-Cerus to regain Asian rights for blood safety system - Reuters 08.24.10 | 05:08 pm
- Cerus: An Unknown Gem That's Primed for a Boost - Seeking Alpha 05.18.10 | 02:05 pm
- Tengion's IPO Comes In Well Below Initial Range: Biotech's Latest Deals, Financings - SeekingAlpha.com 04.11.10 | 08:04 am
- The Return of Buy and Hold? - SeekingAlpha.com 04.06.10 | 10:04 am
- 25 Momentum Stocks for Tuesday - SeekingAlpha.com 04.06.10 | 03:04 am
- Weekly Street Sentiment: Market Continues Up, But Sell-Side Sentiment Eases Lower Again - SeekingAlpha.com 04.05.10 | 12:04 am
- UPDATE 1-Cerus in development deal for blood safety system - Reuters 02.09.10 | 01:02 pm
